Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to DRUG SAFETY & INTERACTIONS

The New England Journal of Medicine

Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy

Hematology/Oncology February 5th 2024

Annals of Internal Medicine

Gabapentinoids and Risk for Severe Exacerbation in Chronic Obstructive Pulmonary Disease

Internal Medicine January 24th 2024

ACP Hospitalist

User-friendly EHRs Also More Safety-friendly

Hospitalist November 28th 2023

Optometry Advisor

PDE5 Inhibitors May Create Unique Visual, Choroidal Changes

Optometry October 30th 2023

The New England Journal of Medicine

Perspective: Wedding Websites, Free Speech, and Adverse Drug Effects

All Specialties October 24th 2023

MDLinx

Danger: Don’t Mix These 8 Meds with Coffee

All Specialties October 24th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form